mchusma

60 ms·

751.
by mchusma 6y ago
So given their planned approval is still a few days away, we can expect about 10,000 deaths between now and the next step. Less than 10,000 have died from vaccines ever, globally, ever. Rolling out these vaccines to the high risk is the eas
752.
by mchusma 6y ago
Interesting. Thanks for sharing the anecdote. Seems odd to me you are asking people. Isn't there a line or something? My biggest concern with virus rollout is millions of doses sitting on shelves waiting for "high priority" p
753.
by mchusma 6y ago
E-signature law is rock solid, there had never in the US been a contract tossed out solely because the signature was electronic. This ship has sailed a long time ago. Scribbling on a dead tree is not superior.
754.
by mchusma 6y ago
I think in practice they are merged to avoid incentives to lie. Every org I have worked at that had separate pools there was widespread lying about being sick. Nobody really asked or cared, so in effect they are the same thing. In practice
755.
by mchusma 6y ago
I think you are being downvoted for the tone, but I agree the problem stripe's customers face is 99% the large fees for credit card processing. Anything they can do here would be good.
756.
by mchusma 6y ago
I recommend mercury.com. Amazing in basically every way IMO.
757.
by mchusma 6y ago
This isn't "fast" we just have low expectations of our government. The FDA in the US is taking 3 weeks to reviews, about 5-10% of the entire time to develop this is just to schedule this (3rd to last) meeting. All while over
758.
by mchusma 6y ago
FDA says Dec 17 meeting to discuss. This contradicts some earlier opinions that the reason the FDA was taking so long to review Pfizer (Dec 10 scheduled date) was that they were planning to review 2-3 candidates together. For context, sched
759.
by mchusma 6y ago
There are plausible criticisms, but the idea that it is simply not possible to power the world with solar, nuclear other renewables and battery is absurd. Most of his arguments seem to be against wind, where his arguments are strongest. Fir
760.
by mchusma 6y ago
Agree with parent. Financial advisors are basically never worth it, for a bunch of reasons, including: -cost is very expensive -none can beat the market, because if they could they would be hedge fund managers or something that makes 100x -
761.
by mchusma 6y ago
I've never been bothered by ads/want to support sites I visit. so never considered using javascript blockers. But I must say I hate GDPR banners and this could convert me.
762.
by mchusma 6y ago
Sure. The right circumstances this can make sense. But at a high level of your SAAS starts at $500/mo, you are selling to mid market and enterprises, not startups, almost universally. I was hoping for a product that would make sense fo
763.
by mchusma 6y ago
Thanks for your work on airflow. 2.0 is exciting and we are looking forward to it. Love airflow 1 though too, it has helped us a ton.
764.
by mchusma 6y ago
(am OP) We haven't had a major outage in 3 years of using airflow. Some issues, and it consumes some time, but so would managed airflow in all likelihood. Most issues are related to "airflow configuration type things" that pr
765.
by mchusma 6y ago
Curious what you like better?
766.
by mchusma 6y ago
I just glanced at our own airflow instance in AWS (not on this service). We run 1 t3.xlarge instances 4vCPU for the scheduler and web server and 1 t3.xlarge instance (4vCPU) for the workers. At $0.33 per hour (on demand), this seems to most
767.
by mchusma 6y ago
I'm reposting some of my thoughts below to try and genuinely see is someone has an answer to the question: From a utilitarian perspective, why weren't these all approved for the elderly in Q2 2020? In other words, its May 2020 and
768.
by mchusma 6y ago
Thanks for responding, I am genuinely curious if my math is wrong so appreciate the discussion. First, regarding "worst case side effects", I am willing to accept your premise that elevated rates of narcolepsy was in the 2009 A(H1
769.
by mchusma 6y ago
I strongly disagree with this. I cannot think of a valid utilitarian argument allowing willing people from getting a vaccine. First, vaccines have an extremely high success rate, 33% of vaccines make it through all trials to approval. 50% a
770.
by mchusma 6y ago
There are over 6 vaccines that have very low expected downside (vaccines rarely have severe side effects and these have none found in thousands of tests)and are all expected to work (>90%). They are all currently banned (people who want
771.
by mchusma 6y ago
At this point there are
772.
by mchusma 6y ago
Mexico should really be complaining about the war on drugs more than the weapons. Cut off the economic fuel for these groups.
773.
by mchusma 6y ago
The issue is they are trying to make 15% seem reasonable. 1.5% is unreasonable. They provide developers negative value, it's just a tax on all transactions.
774.
by mchusma 6y ago
Supervolcanoes and asteroid collisions are good reasons to support nuclear power, not just solar, as a diverse energy source. What happens if the sun gets blocked out?
775.
by mchusma 6y ago
Surprised to see "previously had covid" isn't on the list of criteria. Given that 30%+ of US will have had it by then, makes a big difference in early days of distribution. I do think they should eventually get it but they sh
776.
by mchusma 6y ago
I think people should be given the choice. They should lift the ban now, so people can choose.
777.
by mchusma 6y ago
Better than I thought! Looks like huge growth under covid, and marginally profitable for first time.
778.
by mchusma 6y ago
I will just chime in to say that we love Angular on our team. We love the opinionated, batteries-included philosophy of angular, and it does keep getting better over time. We don't want to have to make the decisions that are required f
779.
by mchusma 6y ago
Agree price is the main issue. Veggie burgers currently almost never taste better than the alternatives (I believe it's possible but just not achieved yet). So right now I have to buy it solely for the environment. Which is is ok, and
780.
by mchusma 6y ago
I have running notes that said 20M doses by end of year, so 10M people. Oxford/Astrazeneca are the only ones who have alluded to 100M doses in 2020. Everyone else won't get phase III results until 2021: johnson and johnson, merck,

More ›